
Paediatric sepsis is characterized by rapid progression and high mortality. Multiple organ injuries and non-thyroidal illness syndrome (NTIS) are common complications that adversely affect prognosis, although NTIS is often overlooked because of its atypical clinical manifestations. Although several critical illness scoring systems are widely used for prognostic assessment, the Phoenix Sepsis Score (PSS), designed for pediatric sepsis definition rather than severity stratification, has poorly described correlations with conventional scoring systems and unclear prognostic performance.This study aimed to provide evidence to support early risk stratification in children with sepsis. Children with sepsis admitted to the paediatric intensive care unit (PICU) of Tongji Hospital between January 2019 and December 2024 who met the 2024 PSS criteria were retrospectively enrolled. PSS, paediatric Sequential Organ Failure Assessment (pSOFA), Paediatric Multiple Organ Dysfunction Syndrome score (P-MODS), Paediatric Logistic Organ Dysfunction-2 (PELOD-2), Paediatric Risk of Mortality III (PRISM III), and Paediatric Critical Illness Score (PCIS), assessed within the first 24 h after admission, were compared between survivors and non-survivors according to in-hospital outcomes. Correlations between PSS and established illness severity scores were analysed. Multivariate logistic regression was performed to identify independent predictors of mortality among organ injuries occurring within the first 24 h after admission, including pulmonary, cardiac, hepatic, renal, brain, coagulation, and gastrointestinal injuries, as well as NTIS. Receiver operating characteristic curve analysis was used to evaluate the prognostic performance of each scoring system and the number of injured organs for predicting in-hospital mortality. In total, 222 children with sepsis admitted to the PICU were included and categorized into survivor and non-survivor groups according to in-hospital outcomes. The areas under the receiver operating characteristic curve for PSS, pSOFA, P-MODS, PELOD-2, PRISM III, and PCIS for predicting in-hospital mortality were 0.843, 0.858, 0.698, 0.824, 0.817, and 0.689, respectively. PSS, a tool to operationalize pediatric sepsis definition, was significantly correlated with all illness severity scoring systems (p < 0.05), showing moderate positive correlations with pSOFA (r = 0.551) and PELOD-2 (r = 0.531), weaker positive correlations with PRISM III (r = 0.411) and P-MODS (r = 0.328), and a weak negative correlation with PCIS (r = − 0.304). Multivariate logistic regression identified pulmonary injury (odds ratio [OR] = 18.090, 95
The increasing prevalence of children with chronic conditions has led to a growing population of adolescents and young adults (AYAs) requiring transition from pediatric to adult care. Despite evidence supporting structured transition pathways, validated tools to assess transition readiness within multidisciplinary, hospital-based transition programs in the Italian setting are lacking. To culturally adapt and preliminarily validate the sample Transition Readiness Assessment for Youth (TRA) into Italian, creating an Italian version (TRAITA) for use among AYAs with chronic and rare diseases beginning transition to adult care in a tertiary care university hospital. This cross-sectional pilot study was conducted at the Azienda Ospedale-Università di Padova within the newly implemented hospital-based, multidisciplinary structured transition program. The TRA was translated into Italian using forward-backward translation methods and culturally adapted by a multidisciplinary expert panel. The questionnaire was administered to AYAs from 5 pediatric units (hematology-oncology, gastroenterology, pulmonology, diabetology and nephrology) adhering to the transition program. Psychometric properties were evaluated following COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) guidelines, including internal consistency: Cronbach’s alfa(α), McDonald’s omega(ω), split-half reliability(ρ), exploratory factor analysis (EFA), and construct validity through hypothesis testing. The adapted version was administered to 66 AYAs (mean age 19.7 years, range 15–30) with rare and chronic conditions (sickle cell disease, diabetes, gastroenterological, pulmonary and renal diseases).The TRAITA demonstrated very good internal consistency (Cronbach’s α = 0.864; McDonald’s ω = 0.864) and stable split-half reliability (Spearman-Brown coefficient ρ = 0.893). Preliminary Explanatory Factor Analysis(EFA) suggested a multidimensional structure with a four-factor solution explaining 43.2
Biological therapies, particularly monoclonal antibodies (mAbs), are increasingly used in pediatric populations, although safety data remain more limited than in adults. This retrospective study evaluates adverse reactions (ARs) to biologics in children treated at Meyer Children’s Hospital IRCCS, Florence, Italy, between 2006 and 2020. Of 438 children treated with biologics, 52 (11.9
Fulminant myocarditis is a life-threatening condition associated with high mortality in critically ill children, and early identification of patients at risk for fulminant progression remains challenging. This study aimed to evaluate the prognostic value of the Vasoactive-Inotropic Score (VIS), serum albumin, systemic inflammatory indices, and conventional biomarkers in predicting fulminant myocarditis and composite adverse outcomes in pediatric intensive care unit (PICU)–admitted children with acute myocarditis. This single-center retrospective cohort study included 71 children (aged 1 month–18 years) admitted to the 30-bed PICU of Gaziantep City Hospital between January 2024 and January 2026 with a primary diagnosis of acute myocarditis. Patients were classified as fulminant (requiring inotropic or mechanical circulatory support due to hemodynamic disturbance) or non-fulminant. The composite adverse outcome comprised in-hospital mortality, extracorporeal membrane oxygenation (ECMO), continuous renal replacement therapy (CRRT), or invasive mechanical ventilation. All biomarkers were measured within the first 6 h of PICU admission. Children with concomitant sepsis or septic shock at PICU admission were excluded. Receiver operating characteristic (ROC) curve analysis was performed to determine optimal cut-off values and the area under the curve (AUC). Of 71 patients (median age 8.4 years; 59.2